Please Wait.....
Report
Global Compression Therapy Market
Market Report I 2025-09-01 I 350 Pages I Data Bridge Market Research
The global compression therapy market is expected to reach USD 6,430,787.17 thousand by 2032 from USD 4,165,003.24 thousand in 2024, growing at a substantial CAGR of 5.6% in the forecast period of 2025 to 2032.
Market Segmentation:
Global Compression Therapy Market, By Product Technique (Static Compression Therapy and Dynamic Compression Therapy), Product Type (Compression Bandages, Garments For Lymphedema, Stockings For Venous Diseases, Compression Wraps, Pneumatic Compression Devices, and Compression Hosiery & Gauntlets), Application (Varicose Veins, Lymphedema, Chronic Venous Insufficiency (CVI), Deep Vein Thrombosis (DVT), Venous Leg Ulcers, Wound Care, and Sports Injury Management), Patient Group (Adult, Geriatric, and Pediatric), Compression Level (Moderate Compression, Strong Compression, Mild Compression, and Very Strong Compression), Distribution Channels (Hospital, Retail Pharmacies, Ecommerce Platforms, Specialty Clinics, Medical Device Stores, Home Healthcare Providers, and Nursing Homes/Long-Term Care Facilities), Country (U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, and rest of Middle East and Africa) -Industry Trends & Forecast To 2032
Overview of the Global Compression Therapy are:
Driver
- Increasing Sports Injuries & Accidents
Restrain
- Limited Reimbursement and Insurance Coverage
Opportunity
- Growth In Home Based Therapy
Market Players:
The key market players for global Compression Therapy are listed below:
- Solventum (U.S.)
- Cardinal Health (U.S.)
- Smith+Nephew - (U.K.)
- Essity Aktiebolag (publ) (Sweden)
- PAUL HARTMANN AG (Germany)
- Arjo - (Sweden)
- Zimmer Biomet (U.S.)
- NIKE, Inc. (U.S.)
- McKesson Medical-Surgical Inc. (U.S.)
- Getinge (Sweden)
- Convatec Group PLC (U.K.)
- Tactile Medical (U.S.)
- adidas AG (Germany)
- Enovis Corporation (U.S.)
- Molnlycke AB (Sweden)
- Lohmann & Rauscher GmbH & Co. KG (Germany)
- THUASNE, SAS (France)
- SIGVARIS GROUP - (Switzerland)
- Ofa Bamberg GmbH (Germany)
- Medline Industries, LP (U.S.)
- Juzo (Julius Zorn GmbH) (Germany)
- MEDI GmbH & Co. KG (Germany)
- AIROS Medical, Inc. (U.S.)
- Calze G.T. S.r.l (Solidea) (Italy)
- Bauerfeind AG (Germany)
- BIOCOMPRESSION SYSTEMS (U.S.)
- ThermoTek (U.S.)
- Mego Afek ltd. (Israel)
- Ossur (Iceland)
- Huntleigh Healthcare Limited (U.K.)
TABLE OF CONTENTS
1 INTRODUCTION 52
1.1 OBJECTIVES OF THE STUDY 52
1.2 MARKET DEFINITION 52
1.3 OVERVIEW OF THE GLOBAL COMPRESSION THERAPY MARKET 52
1.4 LIMITATIONS 54
1.5 MARKETS COVERED 54
2 MARKET SEGMENTATION 58
2.1 MARKETS COVERED 58
2.2 GEOGRAPHICAL SCOPE 59
2.3 YEARS CONSIDERED FOR THE STUDY 60
2.4 CURRENCY AND PRICING 60
2.5 DBMR TRIPOD DATA VALIDATION MODEL 61
2.6 MULTIVARIATE MODELLING 64
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 65
2.8 DBMR MARKET POSITION GRID 66
2.9 MARKET APPLICATION COVERAGE GRID 67
2.10 VENDOR SHARE ANALYSIS 68
2.11 SECONDARY SOURCES 69
2.12 ASSUMPTIONS 69
3 EXECUTIVE SUMMARY 70
4 PREMIUM INSIGHTS 74
4.1 PESTAL ANALYSIS 78
4.2 PORTERS FIVE FORCES ANALYSIS 79
4.3 COST ANALYSIS BREAKDOWN 80
4.4 HEALTHCARE ECONOMY 81
4.4.1 HEALTHCARE EXPENDITURE 81
4.4.2 CAPITAL EXPENDITURE 81
4.4.3 CAPEX TRENDS 81
4.4.4 CAPEX ALLOCATION 81
4.4.5 FUNDING SOURCES 81
4.4.6 INDUSTRY BENCHMARKS 81
4.4.7 GDP RATIO IN OVERALL GDP 82
4.4.8 HEALTHCARE SYSTEM STRUCTURE 82
4.4.9 GOVERNMENT POLICIES 82
4.4.10 ECONOMIC DEVELOPMENT 82
4.5 INDUSTRY INSIGHTS 83
4.5.1 MICRO AND MACRO ECONOMIC FACTORS 83
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING 84
4.5.3 KEY PRICING STRATEGIES 85
4.6 INNOVATION TRACKER AND STRATEGIC ANALYSIS 86
4.6.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 86
4.6.1.1 JOINT VENTURES 86
4.6.1.2 MERGERS AND ACQUISITIONS 86
4.6.1.3 LICENSING AND PARTNERSHIP 86
4.6.1.4 TECHNOLOGY COLLABORATIONS 86
4.6.1.5 STRATEGIC DIVESTMENTS 86
4.6.2 NUMBER OF PRODUCTS IN DEVELOPMENT 86
4.6.3 STAGE OF DEVELOPMENT 87
4.6.4 TIMELINES AND MILESTONES 87
4.6.5 INNOVATION STRATEGIES AND METHODOLOGIES 87
4.6.6 RISK ASSESSMENT AND MITIGATION 87
4.6.7 FUTURE OUTLOOK 87
4.7 OPPORTUNITY MAP ANALYSIS 88
4.8 PATENT ANALYSIS - 89
4.8.1 PATENT QUALITY AND STRENGTH 89
4.8.2 PATENT FAMILIES 89
4.8.3 LICENSING AND COLLABORATIONS 90
4.8.4 COMPETITIVE LANDSCAPE 90
4.8.5 IP STRATEGY AND MANAGEMENT 91
4.8.6 OTHER OBSERVATIONS 91
4.9 REIMBURSEMENT FRAMEWORK 93
4.10 SUPPLY CHAIN ECOSYSTEM 94
4.10.1 PROMINENT COMPANIES 94
4.10.2 SMALL & MEDIUM SIZE COMPANIES 95
4.10.3 END USERS 95
4.11 TECHNOLOGY ROADMAP 96
4.12 TARIFFS & IMPACT ON THE MARKET 98
4.12.1 CURRENT TARIFF RATE(S) IN TOP-5 COUNTRY MARKETS 98
4.13 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 99
4.14 VENDOR SELECTION CRITERIA DYNAMICS 99
4.15 IMPACT ON SUPPLY CHAIN 100
4.15.1 RAW MATERIAL PROCUREMENT 100
4.15.2 MANUFACTURING AND PRODUCTION 100
4.15.3 LOGISTICS AND DISTRIBUTION 100
4.15.4 PRICE PITCHING AND POSITION OF MARKET 100
4.16 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 101
4.16.1 SUPPLY CHAIN OPTIMIZATION 101
4.16.2 JOINT VENTURE ESTABLISHMENTS 101
4.17 IMPACT ON PRICES 101
4.18 REGULATORY INCLINATION 101
4.18.1 GEOPOLITICAL SITUATION 101
4.18.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES 101
4.18.2.1 FREE TRADE AGREEMENTS: 101
4.18.2.2 ALLIANCES ESTABLISHMENTS: 101
4.18.3 STATUS ACCREDITATION (INCLUDING MFTN) 102
4.18.4 DOMESTIC COURSE OF CORRECTION 102
4.18.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS: 102
4.18.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS: 102
4.19 PRICE INDEX 102
5 REGULATORY FRAMEWORK 103
6 MARKET OVERVIEW 113
6.1 DRIVERS 115
6.1.1 RISING PREVALENCE OF CHRONIC VENOUS DISORDERS GLOBALLY 115
6.1.2 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATION 115
6.1.3 INCREASING SPORTS INJURIES & ACCIDENTS 116
6.1.4 INCREASING AWARENESS OF THERAPY BENEFITS 117
6.2 RESTRAINTS 118
6.2.1 LIMITED REIMBURSEMENT AND INSURANCE COVERAGE 118
6.2.2 AVAILABILITY OF ALTERNATIVE TREATMENT 119
6.3 OPPORTUNITIES 120
6.3.1 GROWTH IN HOME BASED THERAPY 120
6.3.2 POST-SURGICAL CARE & REHABILITATION 120
6.3.3 RISING LIFESTYLE-RELATED DISEASES 121
6.4 CHALLENGES 122
6.4.1 LACK OF STANDARDIZED THERAPY PROTOCOLS 122
6.4.2 ENSURING ACCURATE PRODUCT FIT AND CORRECT APPLICATION 123
7 GLOBAL COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE 124
7.1 OVERVIEW 125
7.2 STATIC COMPRESSION THERAPY 128
7.2.1 COMPRESSION STOCKINGS 129
7.2.2 COMPRESSION BANDAGES 129
7.2.3 COMPRESSION SLEEVES 129
7.2.4 COMPRESSION WRAPS 129
7.2.5 COMPRESSION GLOVES/GAUNTLETS 129
7.3 DYNAMIC COMPRESSION THERAPY 130
7.3.1 PNEUMATIC COMPRESSION DEVICES 130
7.3.2 ADAPTIVE COMPRESSION THERAPY DEVICES 130
8 GLOBAL COMPRESSION THERAPY MARKET, BY PRODUCT TYPE 131
8.1 OVERVIEW 132
8.2 COMPRESSION BANDAGES 136
8.2.1 SHORT STRETCH BANDAGES 137
8.2.2 LONG STRETCH BANDAGES 137
8.2.3 MULTILAYER COMPRESSION BANDAGES 137
8.3 COMPRESSION GARMENTS FOR LYMPHEDEMA 138
8.3.1 LEG GARMENTS 139
8.3.2 ARM SLEEVES 139
8.3.3 HAND GLOVES 139
8.3.4 TORSO/TRUNK GARMENTS 139
8.3.5 FACE/HEAD GARMENTS 139
8.4 COMPRESSION STOCKINGS FOR VENOUS DISEASES 140
8.4.1 BELOW KNEE STOCKINGS 141
8.4.2 THIGH HIGH STOCKINGS 141
8.4.3 PANTYHOSE/FULL LEG STOCKINGS 141
8.4.4 MATERNITY STOCKINGS 141
8.5 COMPRESSION WRAPS 141
8.6 PNEUMATIC COMPRESSION DEVICES 142
8.7 COMPRESSION HOSIERY & GAUNTLETS 142
9 GLOBAL COMPRESSION THERAPY MARKET, BY APPLICATION 143
9.1 OVERVIEW 144
9.2 VARICOSE VEINS 148
9.3 LYMPHEDEMA 148
9.4 CHRONIC VENOUS INSUFFICIENCY (CVI) 149
9.5 DEEP VEIN THROMBOSIS (DVT) 149
9.6 VENOUS LEG ULCERS 150
9.7 WOUND CARE 150
9.8 SPORTS INJURY MANAGEMENT 151
10 GLOBAL COMPRESSION THERAPY MARKET, BY PATIENT GROUP 152
10.1 OVERVIEW 153
10.2 ADULT 156
10.3 GERIATRIC 157
10.4 PEDIATRIC 157
11 GLOBAL COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL 158
11.1 OVERVIEW 159
11.2 MODERATE COMPRESSION 162
11.3 STRONG COMPRESSION 163
11.4 MILD COMPRESSION 164
11.5 VERY STRONG COMPRESSION 164
12 GLOBAL COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS 165
12.1 OVERVIEW 166
12.2 HOSPITALS 170
12.2.1 BANDAGES 171
12.2.2 POST-OPERATIVE COMPRESSION STOCKINGS 171
12.2.3 PNEUMATIC COMPRESSION DEVICES 171
12.3 RETAIL PHARMACIES 171
12.3.1 MILD TO MODERATE COMPRESSION STOCKINGS 172
12.3.2 COMPRESSION BANDAGES 172
12.3.3 SLEEVES AND GAUNTLETS 172
12.4 ECOMMERCE PLATFORMS 173
12.4.1 COMPRESSION STOCKINGS & GARMENTS 174
12.4.2 COMPRESSION WRAPS 174
12.4.3 SLEEVES, GLOVES, AND SOCKS 174
12.4.4 PORTABLE PNEUMATIC DEVICES 174
12.5 SPECIALTY CLINICS 174
12.5.1 HIGH-PRESSURE COMPRESSION GARMENTS 175
12.5.2 PNEUMATIC COMPRESSION PUMPS 175
12.5.3 CUSTOM WRAPS 175
12.6 MEDICAL DEVICE STORES 176
12.6.1 COMPRESSION STOCKINGS 177
12.6.2 COMPRESSION BANDAGES 177
12.6.3 COMPRESSION WRAPS 177
12.6.4 PNEUMATIC COMPRESSION DEVICES 177
12.6.5 ADAPTIVE COMPRESSION SYSTEMS 177
12.7 HOME HEALTHCARE PROVIDERS 178
12.7.1 COMPRESSION WRAPS 179
12.7.2 SLEEVES & GARMENTS 179
12.7.3 BANDAGES 179
12.7.4 PNEUMATIC PUMPS (PORTABLE) 179
?
12.8 NURSING HOMES/LONG-TERM CARE FACILITIES 179
12.8.1 COMPRESSION WRAPS 180
12.8.2 SLEEVES AND GAUNTLETS 180
12.8.3 ADAPTIVE GARMENTS 180
13 GLOBAL COMPRESSION THERAPY MARKET, BY REGION 181
13.1 OVERVIEW 182
13.2 NORTH AMERICA 185
13.2.1 U.S. 194
13.2.2 CANADA 201
13.2.3 MEXICO 207
13.3 EUROPE 213
13.3.1 GERMANY 221
13.3.2 FRANCE 228
13.3.3 U.K. 234
13.3.4 ITALY 240
13.3.5 SPAIN 246
13.3.6 SWITZERLAND 252
13.3.7 RUSSIA 258
13.3.8 BELGIUM 264
13.3.9 NETHERLANDS 270
13.3.10 TURKEY 276
13.3.11 REST OF EUROPE 282
13.4 ASIA-PACIFIC 283
13.4.1 CHINA 291
13.4.2 JAPAN 298
13.4.3 INDIA 304
13.4.4 SOUTH KOREA 310
13.4.5 AUSTRALIA 316
13.4.6 INDONESIA 322
13.4.7 SINGAPORE 328
13.4.8 THAILAND 334
13.4.9 MALAYSIA 340
13.4.10 PHILIPPINES 346
13.4.11 VIETNAM 352
13.4.12 REST OF ASIA-PACIFIC 358
1.1 SOUTH AMERICA 359
13.4.13 BRAZIL 366
13.4.14 ARGENTINA 372
13.4.15 REST OF SOUTH AMERICA 378
?
1.2 MIDDLE EAST AND AFRICA 379
13.4.16 SOUTH AFRICA 386
13.4.17 SAUDI ARABIA 392
13.4.18 EGYPT 398
13.4.19 U.A.E. 404
13.4.20 ISRAEL 410
13.4.21 KUWAIT 416
13.4.22 REST OF MIDDLE EAST AND AFRICA 422
14 GLOBAL COMPRESSION THERAPY MARKET: COMPANY LANDSCAPE 423
14.1 COMPANY SHARE ANALYSIS: GLOBAL 423
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 424
14.3 COMPANY SHARE ANALYSIS: EUROPE 425
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 426
15 SWOT ANALYSIS 427
16 COMAPANY PROFILES 428
16.1 SOLVENTUM 428
16.1.1 COMPANY SNAPSHOT 428
16.1.2 REVENUE ANALYSIS 428
16.1.3 COMPANY SHARE ANALYSIS 429
16.1.4 PRODUCT PORTFOLIO 429
16.1.5 RECENT DEVELOPMENT 429
16.2 CARDINAL HEALTH 430
16.2.1 COMPANY SNAPSHOT 430
16.2.2 REVENUE ANALYSIS 430
16.2.3 COMPANY SHARE ANALYSIS 431
16.2.4 PRODUCT PORTFOLIO 431
16.2.5 RECENT DEVELOPMENT 432
16.3 SMITH+NEPHEW 433
16.3.1 COMPANY SNAPSHOT 433
16.3.2 REVENUE ANALYSIS 433
16.3.3 COMPANY SHARE ANALYSIS 434
16.3.4 PRODUCT PORTFOLIO 434
16.3.5 RECENT DEVELOPMENT 435
?
16.4 ESSITY AKTIEBOLAG (PUBL) 436
16.4.1 COMPANY SNAPSHOT 436
16.4.2 REVENUE ANALYSIS 436
16.4.3 COMPANY SHARE ANALYSIS 437
16.4.4 PRODUCT PORTFOLIO 437
16.4.5 RECENT DEVELOPMENT 439
16.5 PAUL HARTMANN AG 440
16.5.1 COMPANY SNAPSHOT 440
16.5.2 REVENUE ANALYSIS 440
16.5.3 COMPANY SHARE ANALYSIS 441
16.5.4 PRODUCT PORTFOLIO 441
16.5.5 RECENT DEVELOPMENT 441
16.6 ADIDAS AG 442
16.6.1 COMPANY SNAPSHOT 442
16.6.2 REVENUE ANALYSIS 442
16.6.3 PRODUCT PORTFOLIO 443
16.6.4 RECENT DEVELOPMENT 443
16.7 AIROS MEDICAL, INC. 444
16.7.1 COMPANY SNAPSHOT 444
16.7.2 PRODUCT PORTFOLIO 444
16.7.3 RECENT DEVELOPMENT 445
16.8 ARJO 446
16.8.1 COMPANY SNAPSHOT 446
16.8.2 REVENUE ANALYSIS 446
16.8.3 PRODUCT PORTFOLIO 447
16.8.4 RECENT DEVELOPMENTS 447
16.9 BAUERFEIND 448
16.9.1 COMPANY SNAPSHOT 448
16.9.2 PRODUCT PORTFOLIO 448
16.9.3 RECENT DEVELOPMENT 449
16.10 BIOCOMPRESSION SYSTEMS 450
16.10.1 COMPANY SNAPSHOT 450
16.10.2 PRODUCT PORTFOLIO 450
16.10.3 RECENT DEVELOPMENT 450
16.11 CALZE G.T.S.R.L 451
16.11.1 COMPANY SNAPSHOT 451
16.11.2 PRODUCT PORTFOLIO 451
16.11.3 RECENT DEVELOPMENT 452
?
16.12 CONVATEC GROUP PLC 453
16.12.1 COMPANY SNAPSHOT 453
16.12.2 PRODUCT PORTFOLIO 453
16.12.3 RECENT DEVELOPMENT 454
16.13 ENOVIS CORPORATION 455
16.13.1 COMPANY SNAPSHOT 455
16.13.2 REVENUE ANALYSIS 455
16.13.3 BRAND PORTFOLIO 456
16.13.4 RECENT DEVELOPMENTS 456
16.14 GETINGE 457
16.14.1 COMPANY SNAPSHOT 457
16.14.2 REVENUE ANALYSIS 457
16.14.3 PRODUCT PORTFOLIO 458
16.14.4 RECENT DEVELOPMENT 458
16.15 HUNTLEIGH HEALTHCARE LIMITED 459
16.15.1 COMPANY SNAPSHOT 459
16.15.2 PRODUCT PORTFOLIO 459
16.15.3 RECENT DEVELOPMENT 460
16.16 JUZO 461
16.16.1 COMPANY SNAPSHOT 461
16.16.2 PRODUCT PORTFOLIO 461
16.16.3 RECENT DEVELOPMENT 462
16.17 LOHMANN & RAUSCHER GMBH & CO. KG 463
16.17.1 COMPANY SNAPSHOT 463
16.17.2 PRODUCT PORTFOLIO 463
16.17.3 RECENT DEVELOPMENT 464
16.18 MCKESSON MEDICAL-SURGICAL INC. 465
16.18.1 COMPANY SNAPSHOT 465
16.18.2 REVENUE ANALYSIS 466
16.18.3 PRODUCT PORTFOLIO 466
16.18.4 RECENT DEVELOPMENT 467
16.19 MEDLINE INDUSTRIES, LP 468
16.19.1 COMPANY SNAPSHOT 468
16.19.2 PRODUCT PORTFOLIO 468
16.19.3 RECENT DEVELOPMENTS 469
16.20 MEDI GMBH & CO. KG 470
16.20.1 COMPANY SNAPSHOT 470
16.20.2 PRODUCT PORTFOLIO 470
16.20.3 RECENT DEVELOPMENT 471
?
16.21 MEGO AFEK LTD. 472
16.21.1 COMPANY SNAPSHOT 472
16.21.2 PRODUCT PORTFOLIO 472
16.21.3 RECENT DEVELOPMENT 474
16.22 MOLNLYCKE AB 475
16.22.1 COMPANY SNAPSHOT 475
16.22.2 PRODUCT PORTFOLIO 475
16.22.3 RECENT DEVELOPMENT 476
16.23 NIKE, INC. 477
16.23.1 COMPANY SNAPSHOT 477
16.23.2 REVENUE ANALYSIS 477
16.23.3 PRODUCT PORTFOLIO 478
16.23.4 RECENT DEVELOPMENT 478
16.24 OFA BAMBERG GMBH 479
16.24.1 COMPANY SNAPSHOT 479
16.24.2 PRODUCT PORTFOLIO 479
16.24.3 RECENT DEVELOPMENT 480
16.25 OSSUR 481
16.25.1 COMPANY SNAPSHOT 481
16.25.2 RECENT FINANCIALS 481
16.25.3 PRODUCT PORTFOLIO 482
16.25.4 RECENT DEVELOPMENT 483
16.26 SIGVARIS GROUP 484
16.26.1 COMPANY SNAPSHOT 484
16.26.2 PRODUCT PORTFOLIO 484
16.26.3 RECENT DEVELOPMENT 484
16.27 TACTILE MEDICAL 485
16.27.1 COMPANY SNAPSHOT 485
16.27.2 REVENUE ANALYSIS 485
16.27.3 PRODUCT PORTFOLIO 486
16.27.4 RECENT DEVELOPMENT 486
16.28 THERMOTEK 488
16.28.1 COMPANY SNAPSHOT 488
16.28.2 PRODUCT PORTFOLIO 488
16.28.3 RECENT DEVELOPMENT 488
16.29 THUASNE, SAS 489
16.29.1 COMPANY SNAPSHOT 489
16.29.2 PRODUCT PORTFOLIO 489
16.29.3 RECENT DEVELOPMENT 489
?
16.30 ZIMMER BIOMET 490
16.30.1 COMPANY SNAPSHOT 490
16.30.2 REVENUE ANALYSIS 491
16.30.3 PRODUCT PORTFOLIO 491
16.30.4 RECENT DEVELOPMENTS 492
17 QUESTIONNAIRE 493
18 RELATED REPORTS 497
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security